146 related articles for article (PubMed ID: 8623464)
21. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
Schmidbauer G; Hancock WW; Wasowska B; Binder J; Padberg W; Kupiec-Weglinski JW
Transplant Proc; 1995 Feb; 27(1):427-9. PubMed ID: 7879048
[No Abstract] [Full Text] [Related]
22. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047
[No Abstract] [Full Text] [Related]
23. Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy.
Cohen DS; Fisher RA; Shapiro JH; Goggins WC; Tawes JW; Mills S; Contos M; Ham JM; Schroeder TJ
Transplant Proc; 1996 Oct; 28(5):2501-5. PubMed ID: 8907923
[No Abstract] [Full Text] [Related]
24. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
25. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
[TBL] [Abstract][Full Text] [Related]
26. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
[TBL] [Abstract][Full Text] [Related]
27. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
28. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
Chen H; Wu J; Luo H; Daloze P
Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
[No Abstract] [Full Text] [Related]
29. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of rapamycin in orthotopic small bowel transplantation in the rat.
Marquet RL; de Bruin RW; Heineman E; Jeekel J
Transplant Proc; 1993 Aug; 25(4):2695-6. PubMed ID: 8356718
[No Abstract] [Full Text] [Related]
31. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
32. Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.
Murray AG; Schechner JS; Epperson DE; Sultan P; McNiff JM; Hughes CC; Lorber MI; Askenase PW; Pober JS
Am J Pathol; 1998 Aug; 153(2):627-38. PubMed ID: 9708821
[TBL] [Abstract][Full Text] [Related]
33. Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
Schmidbauer G; Hancock WW; Wasowska BA; Sablinski T; Kupiec-Weglinski JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):712-3. PubMed ID: 8438450
[No Abstract] [Full Text] [Related]
34. Combined effect of rapamycin and cyclosporine in the prevention of rat corneal allograft rejection.
Thompson P; Xu D; Brunette I; Chen H
Transplant Proc; 1998 Jun; 30(4):1033-5. PubMed ID: 9636417
[No Abstract] [Full Text] [Related]
35. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
[TBL] [Abstract][Full Text] [Related]
36. Route of administration determines the efficacy of rapamycin but not the mechanisms of tolerance induced by it in rats.
Lin Y; Rutgeerts O; Waer M
Transplant Proc; 1996 Dec; 28(6):3057. PubMed ID: 8962185
[No Abstract] [Full Text] [Related]
37. Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
Belitsky P; Gulanikar A; He G; Gupta R
Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272
[No Abstract] [Full Text] [Related]
38. Effectiveness of topical immunosuppressants in prevention and treatment of rejection in face allotransplantation.
Gharb BB; Rampazzo A; Altuntas SH; Madajka M; Cwykiel J; Stratton J; Siemionow MZ
Transplantation; 2013 May; 95(10):1197-203. PubMed ID: 23532181
[TBL] [Abstract][Full Text] [Related]
39. Daily topical tacrolimus therapy prevents skin rejection in a rodent hind limb allograft model.
Solari MG; Washington KM; Sacks JM; Hautz T; Unadkat JV; Horibe EK; Venkataramanan R; Larregina AT; Thomson AW; Lee WPA
Plast Reconstr Surg; 2009 Feb; 123(2 Suppl):17S-25S. PubMed ID: 19182660
[TBL] [Abstract][Full Text] [Related]
40. The effect of combined immunosuppression with systemic low-dose cyclosporin and topical fluocinolone acetonide on the survival of rat hind-limb allografts.
Inceoglu S; Siemionow M; Chick L; Craven CM; Lister GD
Ann Plast Surg; 1994 Jul; 33(1):57-65. PubMed ID: 7944198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
